The national institute for communicable diseases (NICD)

Is a resource of knowledge and expertise in regionally relevant communicable diseases to the South African Government, to SADC countries and the African continent.

BLOG POSTS

FOR HEALTHCARE WORKERS-WHAT'S NEW

COVID-19 QUICK REFERENCE FOR HEALTHCARE WORKERSVersion 15 (uploaded 1 Sept 2020)
Read More
A quick reference for healthcare workers that summarises the presentation and management of suspected cases, mandatory information to be provided on lab request forms, specimens required for SARS-CoV-2 PCR testing and much more.
COVID-19 DAILY SYMPTOM MONITORING FORMVersion 8 (uploaded 1 Sept 2020)
Read More
A symptom assessment tool for daily self-monitoring to be completed for a close contact of a confirmed Coronavirus disease 2019 (COVID-19) case.
COVID-19 CONTACT LINE LISTVersion 9 (Uploaded 1 Sept 2020)
Read More
A form to list every close contact of a person under investigation/confirmed COVID-19 case.
UPDATED GUIDELINE: Clinical management of suspected or confirmed COVID-19 disease Version 5 (Updated 24 Aug 2020)
Read More
New changes include recommendations relating to the use of dexamethasone, heparin and remdesivir, recommendation against the use of chloroquine, hydroxychloroquine, or lopinavir/ritonavir outside of a clinical trial and the reduction time to de-isolate the patient from 14 days to 10 days.
Previous
Next

LEARN MORE ABOUT COVID-19

LATEST SCIENTIFIC PUBLICATIONS

The utility of 2009 H1N1 pandemic data in understanding the transmission potential and estimating the burden of COVID-19 in RSA to guide mitigation strategies
The utility of 2009 H1N1 pandemic data in understanding the transmission potential and estimating the burden of COVID-19 in RSA to guide mitigation strategies
Read More
The COVID-19 pandemic has been marked by extreme heterogeneity in both geography and population across the world. Consequently, leveraging local data aligned to the unique South African (SA) context is critical.
COVID-19–We urgently need to start developing an exit strategy
COVID-19–We urgently need to start developing an exit strategy
Read More
With the SARS-CoV-2 pandemic passing one million ill people (1 521 252 confirmed cases and 92 798 reported deaths (WHO Sit Rep 10 April), most countries are occupied with controlling the outbreak. The economic consequences are enormous. The World Trade Organization (WTO) estimates that “commerce could shrink up to 32% and warns against 30s-style protectionism” [WTO, 2020]. With no vaccine and no proven effective treatment, the tools available are limited to physical distancing, which includes quarantine and travel restrictions.
Whole-Genome Sequence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) obtained from a South African Coronavirus Disease 2019 (COVID-19) Patient
Whole-Genome Sequence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) obtained from a South African Coronavirus Disease 2019 (COVID-19) Patient
Read More
A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from a South African patient with coronavirus disease 2019 (COVID-19), who had returned to South Africa after traveling to Italy.
Previous
Next
Close Menu